Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways

Cohen, 2001, Ischemic preconditioning: description, mechanism, and significance, 867 Becker, 1987, Myocardial consequences of reperfusion, Prog Cardiovasc Dis, 30, 23, 10.1016/0033-0620(87)90009-0 Farb, 1993, Myocardial infarct extension during reperfusion after coronary artery occlusion: pathologic evidence, J Am Coll Cardiol, 21, 1245, 10.1016/0735-1097(93)90253-W Vanden Hoek, 1996, Reperfusion injury in cardiac myocytes after simulated ischemia, Am J Physiol, 270, H1334 Matsumura, 1998, Progression of myocardial necrosis during reperfusion of ischemic myocardium, Circulation, 97, 795, 10.1161/01.CIR.97.8.795 Piper, 1998, A fresh look at reperfusion injury, Cardiovasc Res, 38, 291, 10.1016/S0008-6363(98)00033-9 Olafsson, 1987, Reduction of reperfusion injury in the canine preparation by intracoronary adenosine, Circulation, 76, 1135, 10.1161/01.CIR.76.5.1135 Goto, 1991, Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species, Cardiovasc Res, 25, 943, 10.1093/cvr/25.11.943 Todd, 1996, Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence, Ann Thorac Surg, 62, 1364, 10.1016/0003-4975(96)00495-X Vander Heide, 1996, Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs, Cardiovasc Res, 31, 711, 10.1016/S0008-6363(95)00235-9 Xu, 2001, AMP 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2receptors, J Cardiovasc Pharmacol, 38, 474, 10.1097/00005344-200109000-00016 Smits, 1998, Cardioprotective effects of the novel adenosine A1/A2receptor agonist AMP 579 in a porcine model of myocardial infarction, J Pharmacol Exp Ther, 286, 611 Budde, 2000, Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion, Cardiovasc Res, 47, 294, 10.1016/S0008-6363(00)00115-2 Baxter, 2000, Amp579, an A1/A2A agonist, limits infarct size at reperfusion via a p42/p44 MAPK-dependent pathway, Circulation, 102, II212 Xu, 2000, Limitation of infarct size in rabbit hearts by the novel adenosine receptor agonist AMP 579 administered at reperfusion, J Mol Cell Cardiol, 32, 2339, 10.1006/jmcc.2000.1264 Yang, 2004, NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO, J Mol Cell Cardiol, 36, 411, 10.1016/j.yjmcc.2003.12.008 Zhang, 2003, CGX-1051, a peptide from Conus snail venom, attenuates infarction in rabbit hearts when administered at reperfusion, J Cardiovasc Pharmacol, 42, 764, 10.1097/00005344-200312000-00011 Bell, 2003, Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS, J Mol Cell Cardiol, 35, 185, 10.1016/S0022-2828(02)00310-3 Liao, 2002, Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion, Cardiovasc Res, 53, 902, 10.1016/S0008-6363(01)00531-4 Jonassen, 2001, Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling, Circ Res, 89, 1191, 10.1161/hh2401.101385 Baxter, 2001, Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK, J Cardiovasc Pharmacol, 38, 930, 10.1097/00005344-200112000-00015 Zhao, 2003, Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning, Am J Physiol, 285, H579 Yao, 1994, A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs: efficacy, time course, and role of KATPchannels, Circulation, 89, 1229, 10.1161/01.CIR.89.3.1229 Takano, 2000, Differential role of KATPchannels in late preconditioning against myocardial stunning and infarction in rabbits, Am J Physiol, 279, H2350 Fryer, 2001, ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection, Basic Res Cardiol, 96, 136, 10.1007/s003950170063 Patel, 1993, Inhibition of nitric oxide limits infarct size in the in siturabbit heart, Biochem Biophys Res Commun, 194, 234, 10.1006/bbrc.1993.1809 Murry, 1986, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, 74, 1124, 10.1161/01.CIR.74.5.1124 Oldenburg, 2003, Mitochondrial KATPchannels in preconditioning, J Mol Cell Cardiol, 35, 569, 10.1016/S0022-2828(03)00115-9 Oldenburg, 2003, Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATPchannel opening and leads to cardioprotection, Am J Physiol, 286, H468 Xu, 2003, Timing and duration of administration are crucial for antiinfarct effect of AMP 579 infused at reperfusion in rabbit heart, Heart Dis, 5, 368, 10.1097/01.hdx.0000098614.29006.a7 Komalavilas, 1999, Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells, J Biol Chem, 274, 34301, 10.1074/jbc.274.48.34301 Kim, 1999, Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart, Biochem Cell Biol, 77, 559, 10.1139/o99-065